Skip to main content
. Author manuscript; available in PMC: 2021 Jan 4.
Published in final edited form as: JAMA. 2015 Mar 24;313(12):1232–1239. doi: 10.1001/jama.2015.1373

Figure. Decline in Median HCV Viral Load After Initiation of Study Drugs, Days 0–28.

Figure.

Baseline log hepatitis C virus (HCV) viral load was similar in both groups (6.0 [SD, 0.1] IU/mL in patients receiving antiretroviral (ARV) treatment and 6.1 in patients not receiving ARV treatment [SD, 0.3] in [P = .49]). The study drug combination of ledipasvir and sofosbuvir was equally effective in patients not receiving and receiving ARV treatment (P = .78 for total effectiveness). Lower limit of quantification is 12 IU/mL.